Significance of isolated antibody to hepatitis B core antigen in Dutch national vaccination campaign of behavioural high-risk groups

Epidemiology and Infection

Volumn 137, Issue 4, 2009, Pages 495-503

  Koene, R P M ^a,b   Gotz, H M ^c   Van Den Hoek, J A R ^d,e   Heijnen, M L A ^f   Van Steenbergen, J A ^g   Kroes, A C M ^h  

^a Community Health Service Region Nijmegen ^*  (Netherlands)

^b Academic Collaborative Center Public Health AMPHI   (Netherlands)

^c Public Health Service of the Rotterdam Region   (Netherlands)

^d MUNICIPAL HEALTH SERVICE   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f Netherlands Association for Community Health Services (GGD Nederland)   (Netherlands)

^g NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hepatitis B; Infectious disease control; Public health microbiology; Serology

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AGED; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; ENDEMIC DISEASE; FEMALE; GEOGRAPHIC ORIGIN; HEPATITIS B; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; HUMORAL IMMUNITY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; NETHERLANDS; RISK FACTOR; SEROPREVALENCE; SEXUAL BEHAVIOR;

ADOLESCENT; ADULT; AGED; ALGORITHMS; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B VACCINES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; RISK FACTORS; SEXUAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; YOUNG ADULT;

EID: 69949099194     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026880800085X     Document Type: Article

References (20)

1. Heijnen ML, et al. Hepatitis B vaccination project for behavioural risk groups in the Netherlands. Eurosurveillance 2004; 23: 8(52).
2. Draelos M, et al. Significance of isolated antibody to hepatitis B core antigen determined by immune response to hepatitis B vaccination. Journal of the American Medical Association 1987; 258: 1193-1195.
3. Gandhi RT, et al. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals. Clinical Infectious Diseases 2003; 36: 1602-1605.
4. Jilg W, et al. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. Journal of Hepatology 1995; 23: 14-20.
5. Kroes AC, Quint WG, Heijtink RA. Significance of isolated hepatitis B core antibodies detected by enzyme immunoassay in a high risk population. Journal of Medical Virology 1991; 35: 96-100.
6. Lok AS, Lai CL, Wu PC. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: Implications in hepatitis B vaccination programs. Hepatology 1988; 8: 766-770.
7. McIntyre A, et al. Isolated hepatitis B core antibody - can response to hepatitis B vaccine help elucidate the cause? Australia & New Zealand Journal of Medicine 1992; 22: 19-22.
8. McMahon BJ, et al. Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen. Gastroenterology 1992; 103: 590-594.
9. Wedemeyer H, et al. Isolated anti-HBV core phenotype in anti-HCV-positive patients is associated with hepatitis C virus replication. Clinical Microbiology and Infection 2004; 10: 70-72.
10. Gandhi RT, et al. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: Implications for hepatitis B vaccine strategies. Journal of Infectious Diseases 2005; 191: 1435-1441.
11. Helmy A, Al-Sebayel MI. Isolated antibody to hepatitis B core antigen in patients with chronic hepatitis C virus infection. World Journal of Gastroenterology 2006; 12: 4406-4410.
12. Jilg W, et al. Prevalence of markers of hepatitis B in the adult German population. Journal of Medical Virology 2001; 63 96-102.
13. Grob P, et al. Serological pattern 'anti-HBc alone': Report on a workshop. Journal of Medical Virology 2000; 62: 450-455.
14. Gross A, et al. Hepatitis serological finding 'anti-HBc alone', circulating viral DNA and interpretation of findings [in German]. Schweizer Medizinische Wochenschrift 1993; 123: 1193-1202.
15. Schmidt M, et al. Anti-HBc screening of blood donors: A comparison of nine anti-HBc tests. Vox Sanguinis 2006; 91: 237-243.
16. Rotily M, et al. HBV and HIV screening, and hepatitis B immunization programme in the prison of Marseille, France. International Journal of STD AIDS 1997; 8: 753-759.
17. Schifman RB, et al. Significance of isolated hepatitis B core antibody in blood donors. Archives of Internal Medicine 1993; 153: 2261-2266.
18. Schmidt PJ, Leparc GF, Samia CT. Comparison of assays for anti-HBc in blood donors. Transfusion 1988; 28: 389-391.
19. Rodriguez-Mendez ML, et al. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices. Hepatogastroenterology 2003; 50: 2093-2097.
20. Weber B, et al. Hepatitis B virus markers in anti-HBc only positive individuals. Journal of Medical Virology 2001; 64: 312-319.